TARRYTOWN, N.Y. and CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has ...
More than half of patients with polymyalgia rheumatica have a relapse during tapering of glucocorticoid therapy. Previous studies have suggested that interleukin-6 blockade may be clinically useful in ...
The increasing prevalence of polymyalgia rheumatica among the elderly population is boosting the adoption of polymyalgia rheumatica treatment to efficiently control painful myalgia. Furthermore, the ...
Clinicians may have an ambivalent attitude about polymyalgia rheumatica, a disabling disease marked by severe muscle pain and stiffness. On the one hand, it is most rewarding to be able to almost ...
Background: the mainstay of treatment of polymyalgia rheumatica (PMR) is oral glucocorticoids, but randomized controlled trials of treatment are lacking. As a result, there is no evidence from ...
The exact cause of polymyalgia rheumatica (PMR) is unknown. Studies of patients with PMR and giant-cell arteritis indicate that PMR could be a vasculitis limited to the subclavian or axillary arteries ...
PORTLAND, Ore.--(BUSINESS WIRE)--Sparrow Pharmaceuticals today presented data from an ongoing Phase 2 clinical trial of HSD-1 inhibitor clofutriben (SPI-62) and prednisolone in patients with ...
Hosted on MSN
What is Polymyalgia Rheumatica?
Dr John Watterson, MD, FRCPC, discusses what is polymyalgia rheumatica. Suspect sent text saying he would 'take out' Charlie Kirk, FBI says as scrutiny of Patel's performance increases Desi Arnaz: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback